GlobeNewswire Inc | Mar 8, 2021 04:05PM EST

March 08, 2021

MOUNTAIN VIEW, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation(NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company will release financial results for the fourth quarter and full year of 2020 after the close of trading on Monday, March 22, 2021. The Companys management team will host a corresponding conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET.

Investors interested in listening to the conference call may do so by dialing (844) 707-0665 for domestic callers or (703) 326-3030 for international callers, using conference ID: 1137827. A live and archived webcast of the event will be available on the Investors section of the Companys website at: www.iridex.com.

AboutIridexIridexis a worldwide leader in developing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Companys proprietaryMicroPulsetechnology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions.Iridexs current product line is used for the treatment of glaucoma, diabetic macular edema and other retinal diseases.Iridexproducts are sold intheUnited StatesandGermanythrough a direct sales force and in more than 100 countries through a network of independent distributors. For more information, visitwww.iridex.com.

Investor Relations Contact:Leigh Salvo(415) 937-5404investors@iridex.com

Media Contact:Jamie Hall Pascale Communications, LLC.(724) 417-0167pr@iridex.com